Preferred test for detecting herpes simplex virus (HSV) infection in CSF, neonates, or when rapid diagnostic test for suspected HSV infection is necessary.
Qualitative Polymerase Chain Reaction
Lavender (EDTA), pink (K2EDTA), or serum separator tube. OR Amniotic fluid, bronchoalveolar lavage (BAL), CSF, ocular fluid, tissue, vesicle fluid. OR Endocervical specimen in ThinPrep® Pap Test media.
Separate plasma or serum from cells. Transfer 1 mL serum, plasma, amniotic fluid, BAL, CSF, ocular fluid, or ThinPrep specimen to a sterile container. (Min: 0.5 mL)
Tissue: Transfer to a sterile container and freeze immediately.
Vesicle Fluid: Transfer to viral transport media (ARUP supply #12884). Available online through eSupply using ARUP Connect™ or contact ARUP Client Services at (800) 522-2787.
Specimen source required.
Tissue: Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 3 months
All Others: Ambient: 8 hours; Refrigerated: 72 hours; Frozen: 3 months
Compliance Statement B: For laboratory developed tests not using a RUO kit, and for FDA approved, cleared or 510(k) exempt assays with alterations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
|Component Test Code*||Component Chart Name||LOINC|
|0050102||Herpes Simplex Virus Source||31208-2|
|0060041||Herpes Simplex Virus by PCR||5014-6|
- Herpes Simplex Virus, Type 1/2 DNA, Real-Time PCR,
- HSV Types 1 and 2